{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T15:36:03Z","timestamp":1770910563780,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Pharmacotherapy"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.amjopharm.2011.12.004","type":"journal-article","created":{"date-parts":[[2012,1,25]],"date-time":"2012-01-25T23:56:45Z","timestamp":1327535805000},"page":"14-24","source":"Crossref","is-referenced-by-count":45,"title":["Clostridium Difficile Infection in Older Adults: A Review and Update on Its Management"],"prefix":"10.1016","volume":"10","author":[{"given":"Vicki R.","family":"Kee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjopharm.2011.12.004_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrgastro.2010.190","article-title":"Clostridium difficile infection: epidemiology, risk factors and management","volume":"8","author":"Ananthakrishnan","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib2","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1001\/jama.2009.171","article-title":"A 76-year-old man with recurrent Clostridium difficile-associated diarrhea: review of C. difficile infection","volume":"301","author":"Kelly","year":"2009","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10.1016\/j.amjopharm.2011.12.004_bib3","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1086\/591065","article-title":"Strategies to prevent Clostridium difficile infections in acute care hospitals","volume":"29","author":"Dubberke","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1086\/592981","article-title":"Review of current literature on the economic burden of Clostridium difficile infection","volume":"30","author":"Dubberke","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cll.2010.04.001","article-title":"Clostridium difficile","volume":"30","author":"Curry","year":"2010","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/MAJ.0b013e3181e939d8","article-title":"Clostridium difficile infection","volume":"340","author":"Heinlen","year":"2010","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/cc6773","article-title":"Clostridium difficile: the increasingly difficult pathogen","volume":"12","author":"Pop-Vicas","year":"2008","journal-title":"Crit Care"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/MCC.0b013e328324e6ad","article-title":"Clostridium difficile infection: current perspectives","volume":"15","author":"Janka","year":"2009","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib9","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/QCO.0b013e32818be71d","article-title":"Clostridium difficile: changing epidemiology and new treatment options","volume":"20","author":"Kuijper","year":"2007","journal-title":"Curr Opin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.amjopharm.2011.12.004_bib10","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1086\/521863","article-title":"Clinical recognition and diagnosis of Clostridium difficile infection","volume":"46","author":"Bartlett","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib11","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1086\/657116","article-title":"Management of Clostridium difficile infection: thinking inside and outside the box","volume":"51","author":"Gerding","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib12","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/j.1532-5415.2010.02958.x","article-title":"Diagnosis, management, and prevention of Clostridium difficile infection in long-term care facilities: a review","volume":"58","author":"Simor","year":"2010","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib13","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2165\/00003495-200767040-00001","article-title":"Clostridium difficile-associated disease: changing epidemiology and implications for management","volume":"67","author":"Owens","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib14","doi-asserted-by":"crossref","first-page":"834","DOI":"10.4140\/TCP.n.2010.834","article-title":"Clostridium difficile-associated disease: impact of the updated SHEA\/IDSA guidelines","volume":"25","author":"Kincaid","year":"2010","journal-title":"Consult Pharm"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1586\/egh.10.48","article-title":"The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings","volume":"4","author":"Khanna","year":"2010","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib16","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3109\/00365548.2010.499541","article-title":"Results of faecal donor instillation therapy for recurrent Clostridium difficile-associated diarrhoea","volume":"42","author":"Garborg","year":"2010","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib17","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1056\/NEJMe0910055","article-title":"Clostridium difficile\u2014beyond antibiotics","volume":"362","author":"Kyne","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib18","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1097\/CCM.0b013e3181ab8388","article-title":"Clostridium difficile-associated disease and mortality among the elderly critically ill","volume":"37","author":"Zilberberg","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib19","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1053\/j.gastro.2008.12.070","article-title":"Treatment of Clostridium difficile-associated disease","volume":"136","author":"Leffler","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib20","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/jac\/dkn477","article-title":"What have we learned about antimicrobial use and the risks for Clostridium difficile-associated diarrhoea?","volume":"63","author":"Blondeau","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib21","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.mcna.2006.07.011","article-title":"Antimicrobial therapy of Clostridium difficile-associated diarrhea","volume":"90","author":"Bouza","year":"2006","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib22","first-page":"297","article-title":"Fidaxomicin: new therapy for Clostridium difficile-associated diarrhea","volume":"46","author":"Grant","year":"2011","journal-title":"Formulary"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib23","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/SMJ.0b013e3181eab419","article-title":"Clostridium difficile: an update for the primary care clinician","volume":"103","author":"Salkind","year":"2010","journal-title":"South Med J"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib24","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1517\/13543776.2010.511177","article-title":"New antibiotics for selective treatment of gastrointestinal infection caused by Clostridium difficile","volume":"20","author":"Johnson","year":"2010","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/cc6207","article-title":"Bench-to-bedside review: Clostridium difficile colitis","volume":"12","author":"Gould","year":"2008","journal-title":"Crit Care"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib26","first-page":"921","article-title":"Clostridium difficile-associated diarrhea","volume":"71","author":"Schroeder","year":"2005","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib27","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s15010-007-6113-0","article-title":"Clostridium difficile: emergence of hypervirulence and fluoroquinolone resistance","volume":"35","author":"Razavi","year":"2007","journal-title":"Infection"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib28","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1086\/501997","article-title":"Clostridium difficile in long\u2013term-care facilities for the elderly","volume":"23","author":"Simor","year":"2002","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3201\/eid1203.051064","article-title":"Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003","volume":"12","author":"McDonald","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib30","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nrmicro2164","article-title":"Clostridium difficile infection: new developments in epidemiology and pathogenesis","volume":"7","author":"Rupnik","year":"2009","journal-title":"Nat Rev Microbiol"},{"issue":"Suppl 1","key":"10.1016\/j.amjopharm.2011.12.004_bib31","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1086\/655998","article-title":"Global epidemiology of Clostridium difficile infection in 2010","volume":"31","author":"Gerding","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ajic.2006.06.004","article-title":"Implications of the changing face of Clostridium difficile disease for health care practitioners","volume":"35","author":"McFarland","year":"2007","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib33","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jamda.2007.01.098","article-title":"Clostridium difficile in the long-term care setting","volume":"8","author":"Makris","year":"2007","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib34","doi-asserted-by":"crossref","first-page":"544","DOI":"10.7861\/clinmedicine.8-5-544","article-title":"Clostridium difficile infection","volume":"8","author":"Clark","year":"2008","journal-title":"Clin Med"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib35","doi-asserted-by":"crossref","first-page":"ITC41","DOI":"10.7326\/0003-4819-153-7-201010050-01004","article-title":"In the clinic","volume":"153","author":"Hessen","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib36","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1749-6632.2010.05863.x","article-title":"Clostridium difficile: progress and challenges","volume":"1213","author":"Bartlett","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.gerinurse.2007.04.005","article-title":"Clostridium difficile: an emerging epidemic in nursing homes","volume":"28","author":"Crogan","year":"2007","journal-title":"Geriatr Nurs"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib38","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)","volume":"31","author":"Cohen","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jhin.2010.07.024","article-title":"The role of glutamate dehydrogenase for the detection of Clostridium difficile in faecal samples: a meta-analysis","volume":"77","author":"Shetty","year":"2011","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib40","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1345\/aph.1H332","article-title":"Past, present, and future therapies for Clostridium difficile-associated disease","volume":"40","author":"Surowiec","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib41","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1111\/j.1572-0241.2007.01533.x","article-title":"The changing face of Clostridium difficile: what treatment options remain?","volume":"102","author":"Shen","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib42","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2165\/11591230-000000000-00000","article-title":"Recurrent Clostridium difficile infection: what are the treatment options?","volume":"71","author":"van Nispen tot Pannerden","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib43","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1111\/j.1572-0241.2008.02198.x","article-title":"Clinical review of the management of fulminant Clostridium difficile infection","volume":"103","author":"Jaber","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib44","series-title":"Dificid (fidaxomicin) tablets [package insert]","year":"2011"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib45","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa0910812","article-title":"Fidaxomicin versus vancomycin for Clostridium difficile infection","volume":"364","author":"Louie","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib47","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1128\/AAC.01443-07","article-title":"OPT-80 eliminates Clostridium difficile and is sparing of bacteroides species during treatment of C. difficile infection","volume":"53","author":"Louie","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib48","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1099\/mic.0.042010-0","article-title":"A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin","volume":"156","author":"Tannock","year":"2010","journal-title":"Microbiology"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib49","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1086\/506354","article-title":"Prospective, randomized inpatient study of oral metronidazole versus oral metronidazole and rifampin for treatment of primary episode of Clostridium difficile-associated diarrhea","volume":"43","author":"Lagrotteria","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib50","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1086\/506351","article-title":"Nitazoxanide for the treatment of Clostridium difficile colitis","volume":"43","author":"Musher","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib51","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1086\/596552","article-title":"Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study","volume":"48","author":"Musher","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib52","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1086\/511870","article-title":"Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin","volume":"44","author":"Johnson","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib53","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MCG.0b013e31814a4e97","article-title":"Rifaximin in treatment of recurrent Clostridium difficile-associated diarrhea: an uncontrolled pilot study","volume":"43","author":"Garey","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib54","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.anaerobe.2009.08.004","article-title":"Rifaximin redux: treatment of recurrent Clostridium difficile infections with rifaximin immediately post-vancomycin treatment","volume":"15","author":"Johnson","year":"2009","journal-title":"Anaerobe"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib55","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1345\/aph.1Q080","article-title":"Tigecycline for the treatment of severe Clostridium difficile infection","volume":"45","author":"Larson","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib56","first-page":"4","article-title":"Update on Clostridium difficile associated disease","volume":"23","author":"Cloud","year":"2007","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib57","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1572-0241.2006.00465.x","article-title":"Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease","volume":"101","author":"McFarland","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib58","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1592\/phco.30.12.1266","article-title":"Alternative therapies for Clostridium difficile infections","volume":"30","author":"Venuto","year":"2010","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib59","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1056\/NEJMoa0907635","article-title":"Treatment with monoclonal antibodies against Clostridium difficile toxins","volume":"362","author":"Lowy","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjopharm.2011.12.004_bib60","doi-asserted-by":"crossref","first-page":"i","DOI":"10.1093\/cid\/cir288","article-title":"US FDA grants fast-track designation to Sanofi Pasteur's investigational Clostridium difficile vaccine","volume":"52","year":"2011","journal-title":"Clin Infect Dis"}],"container-title":["The American Journal of Geriatric Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594611002248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594611002248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T08:35:50Z","timestamp":1742373350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1543594611002248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S1543594611002248"],"URL":"https:\/\/doi.org\/10.1016\/j.amjopharm.2011.12.004","relation":{},"ISSN":["1543-5946"],"issn-type":[{"value":"1543-5946","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}